Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe Now!

Related Content

Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?

ByThani Jambulingam, PhD

November 7th 2025

Mark Cuban Cost Plus Drug Company Adds Starjemza to Prescription Drug Portfolio

ByNicholas Jacobus

November 6th 2025

Image Credit: Adobe Stock Images/Steve Cukrov

The New Pharma Equation: How DTP, DTC, and DTE are Re-Wiring Healthcare Around Patients

ByRohit Gupta and Robert Rouse

November 6th 2025

Cencora Reveals $1 Billion Investment Plan Enhancing US-Based Distribution Network

ByNicholas Jacobus

November 5th 2025

Image Credit: Adobe Stock Images/GamePixel

Why AI-Augmented Traceability Hubs are the Future of Pharma Serialization

ByDennis Keilbach and Anil Suresh

November 5th 2025

test

Articles in this issue

Newsletter

Related Content

Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?

Mark Cuban Cost Plus Drug Company Adds Starjemza to Prescription Drug Portfolio

The New Pharma Equation: How DTP, DTC, and DTE are Re-Wiring Healthcare Around Patients

Cencora Reveals $1 Billion Investment Plan Enhancing US-Based Distribution Network

Why AI-Augmented Traceability Hubs are the Future of Pharma Serialization

Trending on Pharmaceutical Commerce

Mark Cuban Cost Plus Drug Company Adds Starjemza to Prescription Drug Portfolio

The New Pharma Equation: How DTP, DTC, and DTE are Re-Wiring Healthcare Around Patients

Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?

Direct-to-Patient (DTP): Who Benefits - and Why It’s Different